| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |